Results

Total Results: 1,564 records

Showing results for "participants".

441. Cerebral-Palsy-Feeding Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cerebral-palsy-feeding_executive.pdf
     March 01, 2013 - Population We included studies whose populations included at least 80 percent of participants with CP … Overall, more data on greater numbers of participants, including adults as well as children, are needed … Those studies that provided data to characterize the participants indicated that children in the studies … Participants were followed for 6 months to over a year, and studies assessed outcomes of interest to … Of particular importance is the need to conduct large enough studies to fully characterize both participants

442. Restless-Legs Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
     November 01, 2012 - participants. … The majority of participants in the seven trials who reported race/ethnicity were white.23,24,25,28,32,34,37 … Women constituted 60 percent of all participants randomized. … In the four studies that reported race,40,44-46 study participants were predominantly white. … All participants had primary RLS.

443. Research White Paper_Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression: Data Use and Governance Toolkit (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/outcomes-research-depression.pdf
     October 01, 2021 - Many registry participants are covered entities, and as such, may be required to obtain HIPAA authorizations … Participants Submitting Data to the Registry Participants submitting data to a registry may also be … Registries may consider providing participants with access to only their own data or to their data and … considerations may include participant qualifications, any agreements in place with other parties (e.g., participants

444. Ced-Appendix-3 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced-appendix-3.xlsx
     June 24, 2022 - Pearson Protocol Publically post a protocol Pearson Eligibility Establish eligibility criteria for participants … NAM2019 Could potential study participants accurate report this event or health state? … Pearson Design_population establish eligibility criteria for participants (so that the evidence informs

445. Use of Telehealth During the COVID-19 Era (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/telehealth-covid-19-disposition-comments.pdf
     January 03, 2023 - Use of Telehealth During the COVID-19 Era Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Use of Telehealth During the COVID-19 Era Draft report available for public comment from July 15, 2022, to August 12, 2022. Citation: Hatef E, Wilson RF, Hannum …

446. Medical Therapies for Locally Advanced Gastric Adenocarcinoma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol-amended.pdf
     February 07, 2025 - comprises seven domains which will each be assessed: • Bias due to confounding • Bias in selection of participants … meta-regressing the difference in overall survival between two chemotherapy regimens on the percentage of participants … Factors important to consider include the type or extent of surgery participants in included studies

447. EHC Protocol: Addressing Social Isolation To Improve Health of Older Adults: A Rapid Evidence Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/making-healthcare-safer-IV.pdf
     August 04, 2023 - eligibility and prepare a summary of the study, including author, year, study design, number of study participants … use specific items in the ROBINS- I tool that assess bias due to confounding, bias in selection of participants

448. Preterm-Birth-Terbutaline-Pump Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/preterm-birth-terbutaline-pump_surveillance.pdf
     January 30, 2013 - difference in means = 0.70 weeks, 95% CI range: 0.43–0.48 weeks, 0.92–0.97 weeks).13,15-19 Most participants … Appendix C: Evidence Table (Terbutaline) Author year Study name (if applicable) Study design participants … Published online: January 30, 2013 37   Author year Study name (if applicable) Study design participants … Published online: January 30, 2013 38   Author year Study name (if applicable) Study design participants … : difference in means = 0.70 weeks, 95% CI range: 0.43–0.48 weeks, 0.92–0.97 weeks).13,15-19 Most participants

449. Preterm-Birth-Terbutaline-Pump Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_surveillance.pdf
     January 30, 2013 - difference in means = 0.70 weeks, 95% CI range: 0.43–0.48 weeks, 0.92–0.97 weeks).13,15-19 Most participants … Appendix C: Evidence Table (Terbutaline) Author year Study name (if applicable) Study design participants … Published online: January 30, 2013 37   Author year Study name (if applicable) Study design participants … Published online: January 30, 2013 38   Author year Study name (if applicable) Study design participants … : difference in means = 0.70 weeks, 95% CI range: 0.43–0.48 weeks, 0.92–0.97 weeks).13,15-19 Most participants

450. Disposition of Comments for Technical Brief 29 Women Living With HIV-AIDS (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/women-hiv_disposition-comments.pdf
     November 21, 2016 - Public Reviewer #2 (Laura Cheever) Methods The previous page refers to inclusion if the study had US participants … Inclusion based on US participants is preferable, as author affiliation can change over time and many … Are barriers self-defined by participants or is there some objective measure (e.g., what if a patient … which this applies with (n=X): “Among the studies that reported information on the racial descent of participants … have added this information: Among the 28 studies that reported information on the racial descent of participants

451. Cancer-Ovarian-Contraceptives Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
     June 01, 2013 - Additional elements considered for observational studies included methods for selection of participants … studies representing 6,901 cases and 15,999 controls, and 5 were cohort studies representing 524,463 participants … studies representing 3,552 cases and 4,713 controls, and 1 was a cohort study representing 103,552 participants … studies representing 3,606 cases and 7,759 controls, and 3 were cohort studies representing 198,704 participants … were case-control studies with 1,096 cases and 2,878 controls, and 1 was a cohort study with 3,181 participants

452. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Participants are required to respond to all parameters.

453. Cover Page (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicine-safety-call-center_research.pdf
     September 01, 2007 - Success Factor Implementation Possible IT Solutions Immunity Anonymity of reporters, participants

454. Cover Page (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/it-architecture-for-post-marketing-surveillance-arizona-cert.pdf
     September 01, 2007 - Success Factor Implementation Possible IT Solutions Immunity Anonymity of reporters, participants

455. No Slide Title (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_vulnerable_populations_kreps.ppt
     May 29, 2025 - No Slide Title Communicating Harm and Benefits to Vulnerable Populations Gary L. Kreps, Ph.D. Mandell Professor of Health Communication and Chair Department of Communication George Mason University gkreps@gmu.edu Vulnerable populations in need of relevant health information Elderly Socio-economically deprive…

456. Improving Rural Health Through Telehealth-Guided Provider-to-Provider Communication (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rural-telehealth-disposition-comments.pdf
     December 26, 2022 - authors did not comment on the populations served by the rural telehealth programs: the age of the participants

457. Evidence Summary: CER 231 Care Interventions for People Living With Dementia and Their Caregivers (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-231-dementia-interventions-evidence-summary_0.pdf
     August 01, 2020 - Because we excluded studies with fewer than 10 participants per study arm, we may not have identified

458. Medical Therapies for Locally Advanced Gastric Adenocarcinoma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol.pdf
     January 01, 2024 - comprises seven domains which will each be assessed: • Bias due to confounding • Bias in selection of participants … meta-regressing the difference in overall survival between two chemotherapy regimens on the percentage of participants … Factors important to consider include the type or extent of surgery participants in included studies

459. Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-protocol-amendment.pdf
     March 22, 2023 - Assessing Applicability: Applicability refers to the degree to which study participants are similar … characteristics are similar, then it is expected that outcomes associated with the intervention for study participants … For example, exclusion of participants with psychiatric comorbidities reduces applicability to clinical

460. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - Participants are required to respond to all parameters.